SABBY MANAGEMENT, LLC's Net Worth
$3.14 Million
Who is SABBY MANAGEMENT, LLC?
SABBY MANAGEMENT, LLC has an estimated net worth of $3.14 Million. This is based on reported shares across multiple companies, which include ReShape Lifesciences Inc., Rosetta Genomics Ltd., NUPATHE INC., and Celsus Therapeutics Plc..
SEC CIK
SABBY MANAGEMENT, LLC's CIK is 0001535610
Past Insider Trading and Trends
2018 was SABBY MANAGEMENT, LLC's most active year for acquiring shares with 28 total transactions. SABBY MANAGEMENT, LLC's most active month to acquire stocks was the month of February. 2012 was SABBY MANAGEMENT, LLC's most active year for disposing of shares, totalling 1 transactions. SABBY MANAGEMENT, LLC's most active month to dispose stocks was the month of January. 2014 saw SABBY MANAGEMENT, LLC paying a total of $856,710.07 for 146,589 shares, this is the most they've acquired in one year. In 2019 SABBY MANAGEMENT, LLC cashed out on 1,192,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ReShape Lifesciences Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.96% | -1.18M |
$0.27 | $2,815.26 | 507 |
Jan 31 - Feb 1
| |||
Form 4
| +5.37% | 60.2K |
$0.28 | $16,830.38 | 1.18M |
Jan 29 - Jan 30
| |||
Form 4
| +1.98% | 21.79K |
$0.27 | $5,815.61 | 1.12M |
Jan 24 - Jan 25
| |||
Form 4
| +0.53% | 5.77K |
$0.28 | $1,609.29 | 1.1M |
Jan 22
| |||
Form 4
| +2.28% | 24.39K |
$0.28 | $6,801.31 | 1.09M |
Jan 17 - Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +22.20% | 194.42K |
$0.24 | $46,612.53 | 1.07M |
Jan 15 - Jan 16
| |||
No matching records found |
Rosetta Genomics Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.76% | 7.08K |
$0.35 | $2,479.75 | 941.69K |
Apr 26
| |||
Form 4
| +7.39% | 64.3K |
$0.43 | $27,728.24 | 934.61K |
Mar 16
| |||
Form 4
| +15.96% | 119.76K |
$0.42 | $50,390.85 | 870.31K |
Mar 14 - Mar 15
| |||
Form 4
| +30.59% | 175.83K |
$0.42 | $73,344.93 | 750.55K |
Mar 12 - Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NUPATHE INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23 - Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Celsus Therapeutics Plc. (AKTX) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +2.65% | 20.1K |
$5.03 | $101,130.00 | 778.03K |
Apr 14 - Apr 15
| |||
Form 4
| +0.34% | 2.58K |
$5.35 | $13,788.25 | 757.93K |
Apr 9 - Apr 11
| |||
Form 4
| +9.96% | 68.4K |
$5.59 | $382,520.00 | 755.36K |
Apr 4 - Apr 8
| |||
Form 4
| +1.42% | 28.21K |
$6.37 | $175,534.12 | 2.02M |
Mar 17 - Apr 2
| |||
Form 4
| +2.52% | 16.2K |
$6.66 | $107,946.70 | 658.74K |
Mar 25 - Mar 27
| |||
Form 4
| +1.76% | 11.1K |
$6.83 | $75,791.00 | 642.54K |
Mar 20 - Mar 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Volcon, Inc. (VLCN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.37% | 15.13K |
$1.65 | $24,928.80 | 654.13K |
Aug 8 - Aug 9
| |||
Form 4
| +7.85% | 46.53K |
$1.91 | $81,755.68 | 638.99K |
Aug 6 - Aug 7
| |||
No matching records found |